Tauriga Sciences, Inc.
TAUG · OTC
12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -4.4% | 221.7% | -52.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 54.7% | 44.8% | 54.4% | 58.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,436.7% | -1,225.9% | -1,184.7% | -2,592% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,503.5% | -1,617.5% | -2,494.6% | -2,865.8% |
| EPS Diluted | -0.005 | -0.008 | -0.003 | -0.011 |
| % Growth | 28.9% | -153.3% | 73.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |